PMI bids to gain first ever FDA modified-risk approval for iQOS

Philip Morris International (PMI) this week submitted its iQOS technology for approval as a reduced-risk product by the U.S. Food and Drug Administration (FDA) ...

Restricted content. Do you want to read more?